Akash Chaudhary@Akash17971
Bharat Connect Conference – Rising Stars (SME) | Part 3
Key Management Insights from:
1. Monolithisch India
2. UniHealth Hospitals
3. GSM Foils
4. Influx HealthTech
Below are the important strategic takeaways shared about these companies during the conference, focusing on strategy, capacity expansion, positioning, and growth signals 👇
1⃣ Monolithisch India 🧱
Monolithisch India operates in the refractory materials segment, supplying specialized monolithic refractories used in steel plants and high-temperature industrial processes.
Industry Positioning
Refractories are critical consumables for steel, cement, and metallurgical industries, making demand closely linked with industrial production and steel capacity expansion.
Growth Strategy
Management highlighted a strategy focused on expanding product offerings and strengthening relationships with large steel manufacturers, which remain the primary customers for refractory solutions.
The company is also focusing on operational efficiency and scale expansion, which can improve margins as volumes increase.
Key clues
◾️ Steel production growth directly drives refractory demand.
◾️ Industrial capex cycle can support long-term demand visibility.
◾️ Product diversification may help improve revenue stability.
2⃣ UniHealth Hospitals 🏥
UniHealth Hospitals operates in the multi-specialty healthcare services segment, focusing on hospital infrastructure and specialized medical care across emerging markets.
India Expansion
The company has recently commenced operations of a 52-bed facility in Navi Mumbai, marking its expansion into the Indian healthcare market.
Management expects capacity to increase to around 200 beds by early CY26 as the facility scales up and additional infrastructure becomes operational.
Revenue guidance from the India operations is expected to reach around ₹100–₹150 crore by FY27, supported by improving occupancy and expanding services.
Africa Operations
UniHealth already has a strong presence in Africa, where it operates hospital facilities targeting regions with limited access to quality healthcare.
The African operations currently contribute meaningfully to revenue and provide international diversification for the business model.
Management highlighted that these markets offer significant long-term growth potential due to an underpenetrated healthcare infrastructure.
Strategic Growth Drivers
A key long-term objective for the company is expanding its hospital network to around 1,000 beds by FY27–FY28.
This expansion will be supported through:
1. Capacity additions in existing hospitals
2. New healthcare facilities
3. Increasing patient inflow and improving occupancy rates
The company is also investing in technology and medical infrastructure to enhance clinical capabilities and operational efficiency.
Capital Structure & Funding
Management highlighted that expansion will be supported through a balanced capital structure, combining internal accruals with external funding if required.
This approach allows the company to scale hospital infrastructure while maintaining financial discipline.
Margin Profile
Healthcare businesses typically benefit from operating leverage once occupancy improves.
Management expects EBITDA margins to improve as new facilities stabilize and utilization increases.
Key clues
◾️ Expansion into India with Navi Mumbai hospital marks a major growth step.
◾️ Target of 1,000 beds by FY27–28 indicates aggressive expansion plans.
◾️ Africa operations provide international diversification and growth potential.
◾️ Operating leverage from hospital utilization can improve margins over time.
Key Monitorable
Sustained profitability will depend on successful execution of new facilities, ramp-up of occupancy levels, and effective cost management as the hospital network expands.
3⃣ GSM Foils 📦
GSM Foils operates in the aluminium foil and flexible packaging segment, supplying foil products used primarily in pharmaceutical, FMCG, and food packaging applications.
Manufacturing & Capacity
The company operates a manufacturing facility with:
▪️ Plant size: ~7,973 sq. ft.
▪️ Installed capacity: ~10,000 metric tons per year
▪️ Workforce: ~39 employees
Current capacity utilization is around 72–75%, and management has indicated that utilization could increase to ~90% in the coming months as demand improves and production stabilizes.
New Expansion – Ahmedabad Unit
To support future growth, the company has set up a new leased manufacturing unit in Ahmedabad.
▪️ Additional capacity: ~10,000 metric tons per year
▪️ Capex: ~₹4.5 crore (₹45 million)
This facility is expected to significantly increase the company’s production capabilities and support higher order execution.
Revenue Potential
At 40–50% utilization, the new Ahmedabad unit is expected to generate:
▪️ ₹8–10 crore monthly revenue
(₹80–100 million converted into crores)
As utilization improves over time, the revenue contribution from this facility could increase further.
Operational Strategy
Management is focusing on:
▪️ Increasing plant utilization across facilities
▪️ Expanding relationships with pharmaceutical packaging clients
▪️ Strengthening operational efficiency and production scale
The pharmaceutical packaging segment continues to remain a structurally growing market, which could support demand for aluminium foil packaging products.
Future Outlook
The company’s growth in the coming years will largely depend on:
▪️ Successful ramp-up of the Ahmedabad manufacturing unit
▪️ Achieving higher utilization levels across plants
▪️ Increasing demand from pharmaceutical and FMCG packaging segments
Management expects that improved capacity utilization and higher production volumes could support steady revenue growth and operational leverage over time.
Key clues
◾️ Existing plant utilization moving from ~72–75% toward ~90% could unlock operating leverage.
◾️ New Ahmedabad facility doubles manufacturing capacity and strengthens production scale.
◾️ Pharma and FMCG packaging demand continues to expand structurally.
Key Monitorable
Sustained growth will depend on the successful ramp-up of the new facility, consistent order inflows from pharma packaging clients, and efficient utilization of expanded manufacturing capacity.
4⃣ Influx HealthTech 🧬
Influx HealthTech operates as a CDMO (Contract Development and Manufacturing Organization) in the nutraceutical and wellness products segment, offering formulation development, manufacturing, and packaging services.
Manufacturing & Capacity
The company operates three manufacturing facilities in Palghar, Maharashtra, with certifications including GMP, HACCP, ISO, and FDA registration for food products.
Management has recently commissioned additional manufacturing lines, including:
▪️ Tablet production line
▪️ Liquid manufacturing line
▪️ Capsule manufacturing line
▪️ Sachet production line
The company has also installed an automated beverage production line capable of around 10,000 bottles per hour, which will support higher production throughput.
Capacity Expansion
Management indicated that manufacturing capacity had already expanded by ~25–30% prior to the IPO, and with deployment of IPO proceeds the company expects overall capacity to increase by around 2.5×.
The expansion includes:
▪️ Nutraceutical manufacturing capacity enhancement
▪️ Pet food production line expansion
▪️ Packaging automation upgrades
These initiatives are intended to increase production scale and improve manufacturing efficiency.
Growth Outlook
Management commentary indicates a target to more than double the business by FY27, while maintaining similar profitability levels.
Growth is expected to be supported by:
▪️ Increasing demand for nutraceutical and wellness products
▪️ Expansion of contract manufacturing partnerships with health brands
▪️ Utilization ramp-up of newly installed production lines
Key clues
◾️ Automated beverage line (~10,000 bottles/hour) supports scalable production.
◾️ Manufacturing capacity expected to increase ~2.5× after IPO deployment.
◾️ Growing nutraceutical demand provides structural industry tailwinds.
Source: Bharat Connect Conference – Rising Stars (SME) | Arihant Capital Markets Ltd
Disclaimer: This post is for informational and educational purposes only.
